Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $13.62 billion. The enterprise value is $11.25 billion.
| Market Cap | 13.62B |
| Enterprise Value | 11.25B |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025, before market open.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 193.57 million shares outstanding. The number of shares has decreased by -10.19% in one year.
| Current Share Class | 193.57M |
| Shares Outstanding | 193.57M |
| Shares Change (YoY) | -10.19% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 84.13% |
| Float | 160.97M |
Valuation Ratios
The trailing PE ratio is 724.97 and the forward PE ratio is 11.81. Incyte's PEG ratio is 0.11.
| PE Ratio | 724.97 |
| Forward PE | 11.81 |
| PS Ratio | 3.18 |
| Forward PS | 2.77 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 44.98 |
| P/OCF Ratio | 35.59 |
| PEG Ratio | 0.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 37.10, with an EV/FCF ratio of 37.16.
| EV / Earnings | 528.92 |
| EV / Sales | 2.55 |
| EV / EBITDA | 37.10 |
| EV / EBIT | 53.64 |
| EV / FCF | 37.16 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.04 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.14 |
| Interest Coverage | 83.55 |
Financial Efficiency
Return on equity (ROE) is 0.47% and return on invested capital (ROIC) is 2.87%.
| Return on Equity (ROE) | 0.47% |
| Return on Assets (ROA) | 2.03% |
| Return on Invested Capital (ROIC) | 2.87% |
| Return on Capital Employed (ROCE) | 5.21% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $8,128 |
| Employee Count | 2,617 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 43.54 |
Taxes
In the past 12 months, Incyte has paid $293.39 million in taxes.
| Income Tax | 293.39M |
| Effective Tax Rate | 93.24% |
Stock Price Statistics
The stock price has increased by +15.88% in the last 52 weeks. The beta is 0.68, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +15.88% |
| 50-Day Moving Average | 65.79 |
| 200-Day Moving Average | 68.03 |
| Relative Strength Index (RSI) | 58.80 |
| Average Volume (20 Days) | 1,909,947 |
Short Selling Information
The latest short interest is 8.19 million, so 4.23% of the outstanding shares have been sold short.
| Short Interest | 8.19M |
| Short Previous Month | 8.43M |
| Short % of Shares Out | 4.23% |
| Short % of Float | 5.09% |
| Short Ratio (days to cover) | 4.28 |
Income Statement
In the last 12 months, Incyte had revenue of $4.41 billion and earned $21.27 million in profits. Earnings per share was $0.10.
| Revenue | 4.41B |
| Gross Profit | 1.64B |
| Operating Income | 209.72M |
| Pretax Income | 351.14M |
| Net Income | 21.27M |
| EBITDA | 303.28M |
| EBIT | 209.72M |
| Earnings Per Share (EPS) | $0.10 |
Balance Sheet
The company has $2.41 billion in cash and $43.12 million in debt, giving a net cash position of $2.37 billion or $12.22 per share.
| Cash & Cash Equivalents | 2.41B |
| Total Debt | 43.12M |
| Net Cash | 2.37B |
| Net Cash Per Share | $12.22 |
| Equity (Book Value) | 3.67B |
| Book Value Per Share | 18.93 |
| Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was $382.59 million and capital expenditures -$79.88 million, giving a free cash flow of $302.71 million.
| Operating Cash Flow | 382.59M |
| Capital Expenditures | -79.88M |
| Free Cash Flow | 302.71M |
| FCF Per Share | $1.56 |
Margins
Gross margin is 37.05%, with operating and profit margins of 4.75% and 0.48%.
| Gross Margin | 37.05% |
| Operating Margin | 4.75% |
| Pretax Margin | 7.13% |
| Profit Margin | 0.48% |
| EBITDA Margin | 6.87% |
| EBIT Margin | 4.75% |
| FCF Margin | 6.86% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.19% |
| Shareholder Yield | 10.19% |
| Earnings Yield | 0.16% |
| FCF Yield | 2.22% |
Analyst Forecast
The average price target for Incyte is $73.81, which is 4.93% higher than the current price. The consensus rating is "Hold".
| Price Target | $73.81 |
| Price Target Difference | 4.93% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | -0.20% |
| EPS Growth Forecast (5Y) | 95.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 4.85 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.85 |
| Piotroski F-Score | 5 |